Detoxification title image

Detoxification

Gut & Immune Health

The body continually processes substances from food, normal metabolism, and everyday exposures. The liver, kidneys, and digestive system each play distinct roles in that work, with many of the underlying processes relying on adequate nutrition. Supporting these normal functions gives detoxification a practical place within everyday health. Different nutritional approaches focus on different parts of the system. Amino acids and micronutrients contribute to metabolic and antioxidant pathways, while fiber supports normal bowel function and waste elimination. A targeted ingredient should have a clear role within that picture, helping you understand what a product is intended to support. The wider aim is consistent, comfortable function. Digestive regularity, adequate intake, and sensible everyday habits provide more useful context than a brief cleansing sensation. Choosing a specific priority helps keep the routine manageable and connects nutritional support with the body’s ongoing processing needs rather than an increasingly complicated collection of products.

Warnings

  • Use charcoal for a specific purpose: Activated charcoal can reduce medicine absorption and has specific medical uses. Do not use it routinely for general detoxification or self-manage a suspected poisoning or harmful exposure.
  • Liver and kidney concerns need specific care: Seek appropriate advice for a suspected organ problem or harmful exposure. A supplement cleanse cannot identify the cause, and some products can worsen liver, kidney, or fluid-balance problems.
  • Check medicine interactions: Ask a pharmacist or clinician to review your exact products alongside your medicines. The ingredient, amount, and treatment determine which combinations are suitable.
  • Pregnancy and breastfeeding: Supplement safety and nutritional needs differ during pregnancy and breastfeeding. Review products with an appropriate clinician, especially herbal mixtures, hormone-marketed products, and high-dose vitamins.
Ingredient overview

Goal guidance

Lifestyle changes

Support everyday health with regular movement, consistent sleep, and sensible alcohol habits. Use appropriate protection around workplace or environmental exposures and keep bowel habits comfortable and regular.

Diet changes

Eat enough varied food, including protein and fiber-rich plants, and stay appropriately hydrated. Regular meals offer a practical foundation for the body’s normal processing functions.

Who this is for

Adults interested in supporting normal liver function, antioxidant defenses, and digestive regularity as part of everyday health.

Who should be careful

Review products with liver or kidney disease, regular medicines, pregnancy, or breastfeeding. Charcoal and fiber can affect medicine absorption; suspected harmful exposures need specific medical advice.

Expected timeline

Follow practical changes such as digestive regularity and consistency of daily habits. Support for normal processing functions is ongoing and is not measured by a brief cleansing sensation.

Common mistakes

Restrictive cleanses, unnecessary laxatives, and excessive supplement combinations can make a routine harder on the body. Focus on adequate food, regular digestion, and a clear reason for each ingredient.

Ingredients

Folate Vitamins
Impact
Highest effect
Typical dose400–800 mcg / day

Folate, along with B6 and B12, is essential for the methylation cycle, a major route for neutralizing hormones and various toxins.

Focuses on
Arsenic methylationLiver enzyme regulationHeavy metal levelsDrug-induced liver injuryPhase II methylation
Most relevant for
Individuals with low folate status, environmental arsenic exposure, or those taking medications like methotrexate that impact folate metabolism.

Potential benefits

  • Arsenic Detoxification Support.Folate facilitates the methylation and subsequent urinary excretion of arsenic, particularly in individuals with low baseline folate levels.
  • Liver Protection During Medication.Supplementation helps maintain normal liver enzyme levels in individuals taking medications like methotrexate that interfere with folate metabolism.
  • Methylation Pathway Role.Unconfirmed. As a critical methyl donor, folate supports Phase II detoxification pathways essential for neutralizing hormones and various toxins.

Limitations

  • Inconsistent Fatty Liver Outcomes.While higher folate is associated with lower fatty liver risk, clinical trials have not consistently shown that supplements improve liver fat or enzymes in existing NAFLD.
  • Status-Dependent Efficacy.The evidence for heavy metal detoxification is strongest for individuals with existing folate deficiency; benefits for those with adequate intake are less established.
  • Limited Heavy Metal Evidence.Reported associations between folate and lower blood levels of lead and cadmium are observational and do not prove folate actively removes these metals.

Study evidence

16 studies

Folate supports arsenic processing, with evidence of benefit in arsenic-exposed people who have low folate status. This does not establish a general detoxification effect: links with other metals and liver health are largely observational, and supplementation has not consistently improved fatty liver outcomes.

View ingredient ->
Magnesium Minerals
Impact
Highest effect
Typical dose200–400 mg / day

Magnesium is a cofactor for hundreds of enzymes, including those that create ATP to power liver functions and those involved in synthesizing the master antioxidant, glutathione.

Focuses on
Liver enzyme supportAlcohol recovery supportMetabolic cofactorCellular energyElectrolyte balance
Most relevant for
Individuals supporting liver health or recovering from alcohol use, where magnesium depletion is frequently observed.

Potential benefits

  • Liver enzyme support in specific contexts.Studies show that magnesium may help lower liver enzymes like ALT and AST in individuals with chronic alcohol use or specific cardiovascular conditions.
  • Nutritional support during alcohol recovery.Magnesium is used clinically to address electrolyte depletion and help prevent complications, such as seizures, during medical alcohol withdrawal.
  • Support for metabolic pathways.Unconfirmed. Magnesium is a required cofactor for ATP production and glutathione synthesis, though direct evidence that supplementation enhances toxin clearance in healthy adults is unproven.

Limitations

  • Inconsistent liver health outcomes.A meta-analysis and trials in patients with nonalcoholic fatty liver disease found no significant benefit of magnesium over placebo for improving liver enzyme levels.
  • Lack of general detox evidence.Research primarily focuses on treating clinical deficiencies or specific illnesses rather than enhancing toxin removal in the general population.
  • Clinical setting constraints.Many observed benefits occurred during intensive medical interventions, making it difficult to isolate magnesium's specific contribution to detoxification.
Things to consider

Excessive magnesium intake can lead to diarrhea or gastrointestinal distress. Individuals with kidney disease should seek medical advice before supplementing due to the risk of toxicity.

Study evidence

19 studies

The available evidence does not establish magnesium as a general detoxification aid. Research linked to this goal mainly concerns electrolyte disturbances, liver-related markers or medical care during alcohol withdrawal, rather than improved toxin clearance in healthy people.

View ingredient ->
Milk Thistle Botanicals
Impact
Highest effect
Typical dose150–600 mg / day

The active compound, Silymarin, protects liver cells from damage by stabilizing their membranes and scavenging free radicals produced during Phase I detoxification. It also stimulates liver cell regeneration, ensuring the organ maintains optimal function under metabolic stress.

Focuses on
Liver enzyme levelsHepatoprotectionAntioxidant defenseBiliary excretion markersLiver cell stability
Most relevant for
Individuals seeking to support liver function through enzyme management, especially those with metabolic liver stress or fatty liver concerns.

Potential benefits

  • Liver Enzyme Management.Meta-analyses and clinical trials show silymarin can significantly reduce elevated ALT and AST levels, which are markers of liver cell stress and damage.
  • Antioxidant Support.Milk thistle supplementation may improve antioxidant markers such as total antioxidant capacity, helping to protect liver cells from oxidative stress during metabolic processes.
  • Toxin Removal Claims.Unconfirmed. While frequently marketed for detoxification, there is no direct clinical evidence that milk thistle increases the clearance of toxins from the body in healthy individuals.

Limitations

  • Narrow Clinical Impact.Reductions in liver enzymes do not necessarily equate to improved detoxification, and studies on liver scarring or broader clinical outcomes show less consistent results.
  • Condition Dependent.Benefits appear more likely in metabolic conditions like fatty liver; findings for alcohol-related or drug-induced liver injury are often conflicting or null.
  • Variable Results.Systematic reviews report that up to 34 percent of trials found no significant change or even increases in liver enzymes, suggesting outcomes depend on dosage and the specific population.
Things to consider

Milk thistle is not a substitute for medical treatment of liver disease; some research indicates it may have no protective effect against specific medication-related toxicities or alcohol-induced damage.

Study evidence

46 studies

Milk Thistle extracts may improve some liver enzyme measures in people with liver disease, but results vary and do not establish a general detoxification effect. Lower liver enzymes are not evidence that the supplement removes toxins or improves health in otherwise healthy users.

View ingredient ->
Molybdenum Minerals
Impact
Highest effect
Typical dose50–200 mcg / day

Molybdenum is crucial for the final step in metabolizing sulfur-containing amino acids. A deficiency can lead to an accumulation of toxic sulfites, causing neurological issues and other sensitivities. This makes it a key player in a specific but important detoxification pathway.

Focuses on
Sulfite metabolismEnzyme cofactorSulfur amino acid metabolism
Most relevant for
Individuals seeking to support the natural enzymatic pathways involved in processing sulfites.

Potential benefits

  • Sulfite Breakdown Support.Unconfirmed. Molybdenum serves as a cofactor for sulfite oxidase, an enzyme required to metabolize sulfites; however, no supplied research confirms that supplements improve detoxification in humans.

Limitations

  • Lack of Clinical Evidence.The provided research does not evaluate molybdenum supplements for detoxification and provides no evidence of improved toxin removal.
  • Industrial Context.Data is limited to environmental exposure in industrial regions, which may not apply to the use of dietary supplements in the general population.
  • Potential Toxicity.Research indicates that higher levels of molybdenum exposure are associated with markers of decreased kidney, liver, and lung health.
Things to consider

Excessive molybdenum exposure has been linked to kidney health risks and changes in liver function indicators.

Study evidence

1 study

The supplied evidence does not show that Molybdenum supplements improve detoxification. It instead links higher environmental exposure with poorer kidney health in an industrial-region population, an observational finding that cannot establish either supplement benefits or the effects of ordinary dietary intake.

View ingredient ->
Selenium Minerals
Impact
Highest effect
Typical dose55–200 mcg / day

Without adequate selenium, the body cannot effectively utilize and regenerate its primary antioxidant, glutathione. This mineral is critical for quenching free radicals generated during detoxification and for metabolizing certain heavy metals.

Focuses on
Antioxidant enzyme supportGlutathione cofactorReactive oxygen managementLiver biomarker maintenance
Most relevant for
Individuals with low dietary selenium intake or those seeking to support the biological pathways involved in metabolic antioxidant defense.

Potential benefits

  • Essential Enzymatic Role.Selenium is a required cofactor for glutathione peroxidase, an enzyme system that helps neutralize reactive oxygen species produced during the body's natural metabolic processes.
  • Support in Clinical Settings.Unconfirmed. In specific clinical groups, such as patients undergoing chemotherapy or recovering from liver surgery, selenium may help maintain liver markers, though this effect is not established for general detoxification.
  • Nutritional Status Correction.Unconfirmed. In populations with selenium deficiency, supplementation has been associated with improved liver enzymes, but it is unproven whether this provides a detoxification benefit for healthy individuals.

Limitations

  • No Effect in Healthy Adults.Short-term intervention trials in healthy adults have shown that selenium supplementation does not significantly increase the activity of enzymes specifically responsible for glutathione-mediated detoxification.
  • Uncertainty in Liver Disease.Systematic reviews found no evidence that selenium improves outcomes in liver disease and suggest that antioxidant supplements may sometimes increase liver enzyme levels.
  • Narrow Therapeutic Range.Benefits observed from selenium-biofortified foods are not consistently replicated with standard tablets, and excessive intake can negatively impact liver, thyroid, and lipid health.
Things to consider

Chronic overexposure to selenium is linked to adverse effects on liver function markers, pancreatic enzymes, and thyroid hormone levels.

Study evidence

10 studies

Selenium contributes to antioxidant defenses, but the supplied research does not establish that supplements improve general Detoxification. Favorable liver-related findings mainly involve specific illnesses or nutrient-status differences, while excess exposure is associated with adverse liver and other health markers.

View ingredient ->
Vitamin B12 Vitamins
Impact
Highest effect
Typical dose100–1000 mcg / day

Vitamin B12 is essential for regenerating methionine to fuel the entire methylation cycle.

Focuses on
Cyanide neutralizationMethylation supportHomocysteine regulation
Most relevant for
Individuals requiring clinical intervention for cyanide exposure or those seeking to support biochemical pathways involved in metabolic processing.

Potential benefits

  • Acute cyanide neutralization.Intravenous hydroxocobalamin acts as a medical antidote by binding directly to cyanide, forming a stable complex that the body can safely excrete.
  • Methylation cycle support.Unconfirmed. Serves as an essential cofactor for regenerating methionine, which is necessary for Phase II metabolic reactions, though a direct increase in general toxin clearance is not clinically proven.

Limitations

  • No proven liver cleansing.In trials for non-alcoholic fatty liver disease, oral B12 supplementation failed to significantly improve liver enzymes, fat levels, or fibrosis compared to a placebo.
  • Route and form specificity.The evidence for detoxifying effects is primarily limited to the emergency medical use of hydroxocobalamin rather than daily oral use of standard B12 supplements.
  • Marker versus outcome.While B12 effectively lowers homocysteine levels, this biochemical change has not been shown to translate into broader systemic detoxification benefits in the general population.
Things to consider

Long-term metformin use is associated with reduced B12 levels. High-dose medical administration can cause temporary red discoloration of the skin and urine, or acute kidney injury in critical cases.

Study evidence

8 studies

A specific form of Vitamin B12, intravenous hydroxocobalamin, has a medical role in treating cyanide poisoning. That targeted antidote use does not establish a general detoxification benefit from oral B12 supplements, and the supplied supplementation research does not show clear improvements in liver health.

View ingredient ->

Studies

Explore published research for this goal.

Sources

Up to five highest-ranked published examples per ingredient. Study counts and charts include all published studies for the connection.

  1. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial.
    Asgarshirazi M; Shariat M; Sheikh M · Hepatobiliary & pancreatic diseases international : HBPD INT · 2018
    Randomized trial55 participantsFolate
  2. Homocysteine, folate, and nonalcoholic fatty liver disease: a systematic review with meta-analysis and Mendelian randomization investigation.
    Yuan S; Chen J; Dan L; Xie Y; Sun Y; Li X; Larsson SC · The American journal of clinical nutrition · 2022
    Meta-analysis30,368 participants22 studies pooledFolate
  3. Serum folate levels and urinary arsenic methylation profiles in the US population: NHANES, 2003-2012.
    Zhang X; Xu X; Zhong Y; Power MC; Taylor BD; Carrillo G · Journal of exposure science & environmental epidemiology · 2020
    Cross-sectional study11,016 participantsFolate
  4. Association between serum folate levels and blood concentrations of cadmium and lead in US adults.
    Wu Z; Hu H; Wang C; Wu J; Xiong Y; Fu Y; Cheng X; Su H; Li P · Environmental science and pollution research international · 2022
    Cross-sectional study15,501 participantsFolate
  5. Effects of Folic Acid Supplementation on Liver Enzymes, Lipid Profile, and Insulin Resistance in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial.
    Molaqanbari MR; Zarringol S; Talari HR; Taghizadeh M; Bahmani F; Mohtashamian A; Ebrahimzadeh A; Sharifi N · Advanced biomedical research · 2023
    Randomized trial66 participantsFolate
  6. Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics.
    Gullestad L; Dolva LO; Søyland E; Manger AT; Falch D; Kjekshus J · Alcoholism, clinical and experimental research · 1992
    Randomized trial49 participantsMagnesium
  7. Magnesium Sulfate Administration in Moderate Coronary Artery Disease Patients Improves Atherosclerotic Risk Factors: A Double-Blind Clinical Trial Study.
    Farshidi H; Sobhani AR; Eslami M; Azarkish F; Eftekhar E; Keshavarz M; Soltani N · Journal of cardiovascular pharmacology · 2021
    Randomized trialMagnesium
  8. Effects of Synbiotic Food Consumption on Serum Minerals, Liver Enzymes, and Blood Pressure in Patients with Type 2 Diabetes: A Double-blind Randomized Cross-over Controlled Clinical Trial.
    Asemi Z; Aarabi MH; Hajijafari M; Alizadeh SA; Razzaghi R; Mazoochi M; Esmaillzadeh A · International journal of preventive medicine · 2020
    Randomized trialMagnesium
  9. Clinical experience with 781 cases of alcoholism evaluated and treated on an inpatient basis by various methods.
    Daus AT; Freeman WM; Wilson J; Aponte C · The International journal of the addictions · 1985
    Observational study781 participantsMagnesium
  10. Ionized hypomagnesemia in patients undergoing orthotopic liver transplantation: a complication of citrate intoxication.
    Scott VL; De Wolf AM; Kang Y; Altura BT; Virji MA; Cook DR; Altura BM · Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 1997
    Single-arm trialMagnesium
  11. The effect of silymarin on liver enzymes in patients taking isotretinoin: A randomized clinical trial.
    Mirnezami M; Jafarimanesh H; Rezagholizamenjany M; Alimoradian A; Ranjbaran M · Dermatologic therapy · 2021
    Randomized trial74 participantsMilk Thistle
  12. A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine.
    Moayedi B; Gharagozloo M; Esmaeil N; Maracy MR; Hoorfar H; Jalaeikar M · European journal of haematology · 2013
    Randomized trial97 participantsMilk Thistle
  13. Effect of aerobic training with silymarin consumption on glycemic indices and liver enzymes in men with type 2 diabetes.
    Ghalandari K; Shabani M; Khajehlandi A; Mohammadi A · Archives of physiology and biochemistry · 2023
    Randomized trial60 participantsMilk Thistle
  14. Impact of silymarin-supplemented cookies on liver enzyme and inflammatory markers in non-alcoholic fatty liver disease patients.
    Jaffar HM; Bader Ul Ain H; Tufail T; Hanif A; Malik T · Food science & nutrition · 2024
    Clinical trial64 participantsMilk Thistle
  15. Impact of Silymarin Supplements on Liver Enzyme Levels: A Systematic Review.
    Calderon Martinez E; Herrera D; Mogan S; Hameed Z; Jangda AA; Khan TJ; Mroke P; Sajid S; Shah YR; Baig I · Cureus · 2023
    Systematic review3,846 participants29 studies pooledMilk Thistle
  16. Human molybdenum exposure risk in industrial regions of China: New critical effect indicators and reference dose.
    Kuang HX; Li MY; Zeng XW; Chen D; Zhou Y; Zheng T; Xiang MD; Wu QZ; Chen XC; Dong GH; Yu YJ · Ecotoxicology and environmental safety · 2024
    Cross-sectional study2,267 participantsMolybdenum
  17. Supplementation with selenium can influence nausea, fatigue, physical, renal, and liver function of children and adolescents with cancer.
    Vieira ML; Fonseca FL; Costa LG; Beltrame RL; Chaves CM; Cartum J; Alves SI; Azzalis LA; Junqueira VB; Pereria EC; Rocha KC · Journal of medicinal food · 2015
    Randomized trialSelenium
  18. [Selenium and oxidative stress in cancer patients].
    Gorozhanskaia ÉG; Sviridova SP; Dobrovol'skaia MM; Zybrikhina GN; Kashnia ShR · Biomeditsinskaia khimiia · 2014
    Single-arm trial40 participantsSelenium
  19. Comprehensive Insights into the Health Effects of Selenium Exposure and Supplementation Among the Chinese Community Middle-Aged and Elderly: a Combined Retrospective Cohort Study and Intervention Study.
    Li C; Peng X; Zheng J; Shi K; Qin L; Yang Q; Wang Z; Liu Y; Huang L · Biological trace element research · 2024
    Other40 participantsSelenium
  20. Heavy metals and metalloids exposure and liver function in Chinese adults - A nationally representative cross-sectional study.
    Wang S; Lyu Y; Ji S; Liu N; Wu B; Zhao F; Li Z; Qu Y; Zhu Y; Xie L; Li Y; Zhang Z; Song H; Hu X; Qiu Y; Zheng X; Zhang W; Yang Y; Li F; Cai J; Zhu Y; Cao Z; Tan F; Shi X · Environmental research · 2024
    Cross-sectional study9,445 participantsSelenium
  21. Selenium-Biofortified Strawberries Improve Glucose Homeostasis and Hepatic Function: A 30-Day Randomized Controlled Trial in Healthy Adults.
    Vasto S; Di Rosa L; Ferrantelli V; Fiore AS; Giordano CP; Cannizzaro A; Sabatino L; Macaluso A; Caldarella R; Caldara GF; Baldassano S · Nutrients · 2026
    Randomized trial35 participantsSelenium
  22. Antidotes for acute cyanide poisoning.
    Borron SW; Baud FJ · Current pharmaceutical biotechnology · 2013
    Narrative reviewVitamin B12
  23. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation.
    Borron SW; Baud FJ; Barriot P; Imbert M; Bismuth C · Annals of emergency medicine · 2007
    Case series69 participantsVitamin B12
  24. Comment on "Rapid visual detection of blood cyanide" by C. Männel-Croisé and F. Zelder, Analytical Methods, 2012, 4, 2632.
    Kadjo AF; Dasgupta PK; Boss GR · Analytical methods : advancing methods and applications · 2023
    Editorial / commentaryVitamin B12
  25. [Acute intoxication in adults - what you should know].
    Zilker T · Deutsche medizinische Wochenschrift (1946) · 2014
    Narrative reviewActivated CharcoalVitamin B12
  26. Investigating vitamin B12 levels in children with obesity: the role of metformin.
    Iwańska A; Goncerz D; Ahmed M; Aoun R; Kozioł-Kozakowska A; Szczudlik E; Stępniewska A; Wójcik M; Starzyk JB · European journal of pediatrics · 2026
    Observational study500 participantsVitamin B12
  27. Betaine consumption as a new clinical approach to treatment and prophylaxis of folate-related pathologies.
    Yeroshkina K; Rossokha Z; Fishchuk L; Gorovenko N · Nutrition reviews · 2023
    Narrative reviewBetaine Anhydrous
  28. Effects of betaine supplementation on cardiovascular markers: A systematic review and Meta-analysis.
    Ashtary-Larky D; Bagheri R; Ghanavati M; Asbaghi O; Tinsley GM; Mombaini D; Kooti W; Kashkooli S; Wong A · Critical reviews in food science and nutrition · 2022
    Meta-analysisBetaine Anhydrous
  29. Decoding Betaine: A Critical Analysis of Therapeutic Potential Compared with Marketing Hype-A Narrative Review.
    Nikrandt G; Chmurzynska A · The Journal of nutrition · 2024
    Narrative reviewBetaine Anhydrous
  30. Therapy of NAFLD: antioxidants and cytoprotective agents.
    Chang CY; Argo CK; Al-Osaimi AM; Caldwell SH · Journal of clinical gastroenterology · 2006
    Narrative reviewBetaine Anhydrous
  31. Choline and contribution to normal liver function of the foetus and exclusively breastfed infants: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006.
    EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA); Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pentieva K; Thies F; Tsabouri S; Vinceti M; Bresson JL; Fiolet T; Siani A · EFSA journal. European Food Safety Authority · 2024
    Guideline / consensusCholine
  32. Adiposity May Moderate the Link Between Choline Intake and Non-alcoholic Fatty Liver Disease.
    Mazidi M; Katsiki N; Mikhailidis DP; Banach M · Journal of the American College of Nutrition · 2020
    Cross-sectional study20,643 participantsCholine
  33. Choline and Choline-Related Metabolites in Pediatric Short Bowel Syndrome.
    Hilberath J; Shunova A; Heister L; Poets CF; Bernhard W · Nutrients · 2026
    Observational study80 participantsCholine
  34. Choline Supplementation in Cystic Fibrosis-The Metabolic and Clinical Impact.
    Bernhard W; Lange R; Graepler-Mainka U; Engel C; Machann J; Hund V; Shunova A; Hector A; Riethmüller J · Nutrients · 2019
    Single-arm trial10 participantsCholine
  35. 1H MR Spectroscopy at 3T for Hepatic Choline Quantification in Healthy Young Women: A Translational Imaging Study with Dietary Correlation.
    Hawesa H; Alghamdi R; Allam H; Alfaifi B; Alrabiah N; Alghumaiz M; Shanawani M; Alshegri H; Hassan MG · Current medical imaging · 2026
    Cohort study88 participantsCholine
  36. Curcumin supplementation effect on liver enzymes in patients with nonalcoholic fatty liver disease: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.
    Vajdi M; Hassanizadeh S; Hassanizadeh R; Bagherniya M · Nutrition reviews · 2024
    Meta-analysis905 participants15 studies pooledCurcumin
  37. Therapeutic effects of curcumin supplementation on liver enzymes of nonalcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.
    Ebrahimzadeh A; Ebrahimzadeh A; Fooladshekan S; Mohseni S; Mohtashamian A; Babajafari S; Sohrabi Z · Food science & nutrition · 2025
    Meta-analysis14 studies pooledCurcumin
  38. Curcumin Attenuates Liver Steatosis via Antioxidant and Anti-Inflammatory Pathways in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
    Yaikwawong M; Kamdee K; Chuengsamarn S · International journal of molecular sciences · 2025
    Randomized trial227 participantsCurcumin
  39. A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study.
    T Krishnareddy N; Thomas JV; Nair SS; N Mulakal J; Maliakel BP; Krishnakumar IM · BioMed research international · 2019
    Randomized trial48 participantsCurcumin
  40. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ · Nutrition & metabolism · 2024
    Randomized trial84 participantsCurcumin
  41. Efficacy of glutamine supplementation in postoperative patients undergoing hepatic surgery: a systematic review and meta-analysis of randomized controlled trials.
    Meng X; Zhang M; Wang X · Clinics (Sao Paulo, Brazil) · 2026
    Meta-analysis1,198 participants18 studies pooledGlutamine
  42. Glutamine supplementation in preterm infants receiving parenteral nutrition leads to an early improvement in liver function.
    Wang Y; Cai W; Tao YX; Tang QY; Feng Y; Wu J · Asia Pacific journal of clinical nutrition · 2014
    Randomized trial30 participantsGlutamine
  43. Parenteral glutamine protects hepatic function during bone marrow transplantation.
    Brown SA; Goringe A; Fegan C; Davies SV; Giddings J; Whittaker JA; Burnett AK; Poynton CH · Bone marrow transplantation · 1998
    Randomized trial34 participantsGlutamine
  44. Protective effect of parenteral glutamine supplementation on hepatic function in very low birth weight infants.
    Wang Y; Tao YX; Cai W; Tang QY; Feng Y; Wu J · Clinical nutrition (Edinburgh, Scotland) · 2010
    Randomized trial30 participantsGlutamine
  45. A multistrain probiotic increases the serum glutamine/glutamate ratio in patients with cirrhosis: a metabolomic analysis.
    Laghi L; Román E; Lan Q; Nieto JC; Canalda-Baltrons A; Poca M; Sánchez-Rodríguez MB; Clària J; Alvarado E; Cuyàs B; Sánchez E; Vidal S; Guarner C; Escorsell À; Manichanh C; Soriano G · Hepatology communications · 2023
    Randomized trial32 participantsGlutamine
  46. The impact of obesity-associated glycine deficiency on the elimination of endogenous and exogenous metabolites via the glycine conjugation pathway.
    Tan HC; Hsu JW; Tai ES; Chacko S; Kovalik JP; Jahoor F · Frontiers in endocrinology · 2024
    Cohort study42 participantsGlycine
  47. Metabolic impact of dietary glycine supplementation in individuals with severe obesity.
    Tan HC; Hsu JW; Tai ES; Chacko S; Wu V; Yen PM; Kovalik JP; Jahoor F · Scientific reports · 2025
    Single-arm trial19 participantsGlycine
  48. Contribution towards a Metabolite Profile of the Detoxification of Benzoic Acid through Glycine Conjugation: An Intervention Study.
    Irwin C; van Reenen M; Mason S; Mienie LJ; Westerhuis JA; Reinecke CJ · PloS one · 2017
    Non-randomized trial21 participantsGlycine
  49. Glycine conjugation of para-aminobenzoic acid (PABA): a quantitative test of liver function.
    Furuya KN; Durie PR; Roberts EA; Soldin SJ; Verjee Z; Yung-Jato L; Giesbrecht E; Ellis L · Clinical biochemistry · 1996
    Methods validation study74 participantsGlycine
  50. The treatment of isovaleric acidemia with glycine supplement
    M Naglak, R Salvo, K Madsen, P Dembure, L Elsas · Pediatric research · 1988
    Non-randomized trial2 participantsGlycine
  51. Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease.
    Musa-Veloso K; Venditti C; Lee HY; Darch M; Floyd S; West S; Simon R · Nutrition reviews · 2019
    Meta-analysis18 studies pooledOmega-3
  52. Omega-3 polyunsaturated fatty acids in the treatment of non-alcoholic fatty liver disease: An umbrella systematic review and meta-analysis.
    Musazadeh V; Karimi A; Malekahmadi M; Ahrabi SS; Dehghan P · Clinical and experimental pharmacology & physiology · 2023
    Meta-analysis6,561 participants8 studies pooledOmega-3
  53. Effectiveness of ω-3 Polyunsaturated Fatty Acids Based Lipid Emulsions for Treatment of Patients after Hepatectomy: A Prospective Clinical Trial.
    Gong Y; Liu Z; Liao Y; Mai C; Chen T; Tang H; Tang Y · Nutrients · 2017
    Randomized trial119 participantsOmega-3
  54. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Parker HM; Johnson NA; Burdon CA; Cohn JS; O'Connor HT; George J · Journal of hepatology · 2012
    Meta-analysis355 participants9 studies pooledOmega-3
  55. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Aziz T; Niraj MK; Kumar S; Kumar R; Parveen H · Cureus · 2024
    Meta-analysis15 studies pooledOmega-3
  56. Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: A systematic review.
    Noureddin M; Sander-Struckmeier S; Mato JM · World journal of hepatology · 2020
    Systematic review9 studies pooledSAMe
  57. Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial.
    Zhang L; Liu XH; Qi HB; Li Z; Fu XD; Chen L; Shao Y · European review for medical and pharmacological sciences · 2016
    Randomized trial120 participantsSAMe
  58. S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis.
    Guo T; Chang L; Xiao Y; Liu Q · PloS one · 2015
    Meta-analysis705 participants11 studies pooledSAMe
  59. Protective effect of S-adenosylmethionine on hepatic ischemia-reperfusion injury during hepatectomy in HCC patients with chronic HBV infection.
    Liu GY; Wang W; Jia WD; Xu GL; Ma JL; Ge YS; Yu JH; Sun QK; Meng FL · World journal of surgical oncology · 2014
    Non-randomized trial81 participantsSAMe
  60. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.
    Mato JM; Cámara J; Fernández de Paz J; Caballería L; Coll S; Caballero A; García-Buey L; Beltrán J; Benita V; Caballería J; Solà R; Moreno-Otero R; Barrao F; Martín-Duce A; Correa JA; Parés A; Barrao E; García-Magaz I; Puerta JL; Moreno J; Boissard G; Ortiz P; Rodés J · Journal of hepatology · 1999
    Randomized trial123 participantsSAMe
  61. Dietary amino acid taurine ameliorates liver injury in chronic hepatitis patients.
    Hu YH; Lin CL; Huang YW; Liu PE; Hwang DF · Amino acids · 2008
    Non-randomized trial24 participantsTaurine
  62. Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot study.
    Schneider SM; Joly F; Gehrardt MF; Badran AM; Myara A; Thuillier F; Coudray-Lucas C; Cynober L; Trivin F; Messing B · The British journal of nutrition · 2006
    Single-arm trial32 participantsTaurine
  63. Vitamin C supplementation ameliorates liver function profile and antiviral treatment response in Hepatitis C patients.
    Nayila I; Javed MS; Khan MA; Hussain G; Raza Naqvi SA; Ali S; Jabeen Z; Shahnawaz S; Akram R; Iman T; Hassan Dogar MZ; Malik SA · Pakistan journal of pharmaceutical sciences · 2022
    Non-randomized trial200 participantsVitamin C
  64. Effect of ascorbic acid-rich diet on in vivo-induced oxidative stress.
    Alleva R; Di Donato F; Strafella E; Staffolani S; Nocchi L; Borghi B; Pignotti E; Santarelli L; Tomasetti M · The British journal of nutrition · 2012
    Non-randomized trial46 participantsVitamin C
  65. Dietary Vitamin C Intake Is Associated With Improved Liver Function and Glucose Metabolism in Chinese Adults.
    Luo X; Zhang W; He Z; Yang H; Gao J; Wu P; Ma ZF · Frontiers in nutrition · 2022
    Observational study8,307 participantsVitamin C
  66. Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxazole-nitroso in HIV infection.
    Trepanier LA; Yoder AR; Bajad S; Beckwith MD; Bellehumeur JL; Graziano FM · Journal of acquired immune deficiency syndromes (1999) · 2005
    Observational studyVitamin C
  67. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.
    Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA · Toxicology · 2006
    Clinical trial53 participantsVitamin C
  68. Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.
    Vadarlis A; Antza C; Bakaloudi DR; Doundoulakis I; Kalopitas G; Samara M; Dardavessis T; Maris T; Chourdakis M · Journal of gastroenterology and hepatology · 2021
    Meta-analysis8 studies pooledVitamin E
  69. Effect of vitamin E on cardiometabolic factors in paediatric metabolic dysfunction-associated steatotic liver disease: a systematic review with meta-analysis.
    Pam P; Musazadeh V; Mahmoudinezhad M; Panahiyan P; Mansoori MA; Zarrin R; Faghfouri AH · The British journal of nutrition · 2026
    Meta-analysis665 participants11 studies pooledVitamin E
  70. Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial.
    Anushiravani A; Haddadi N; Pourfarmanbar M; Mohammadkarimi V · European journal of gastroenterology & hepatology · 2019
    Randomized trial150 participantsVitamin E
  71. Vitamin E administration reduces liver enzyme levels in patients with Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD): evidence from a systematic review and meta-analysis.
    Karimi M; Abidi M; Gholamian R; Ostovan A; Zakerolhosseini N; Boroomand S; Esmaeili S; Pourramezan MH; Mohebi S; Javadimoghadam A; Behmaneshnia F; Asbaghi O · Nutrition & metabolism · 2026
    Meta-analysis16 studies pooledVitamin E
  72. Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis.
    Banini BA; Cazanave SC; Yates KP; Asgharpour A; Vincent R; Mirshahi F; Le P; Contos MJ; Tonascia J; Chalasani NP; Kowdley KV; McCullough AJ; Behling CA; Schwimmer JB; Lavine JE; Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) · Journal of clinical gastroenterology · 2020
    Randomized trial228 participantsVitamin E
  73. [Therapy of Wilson disease].
    Smolarek C; Stremmel W · Zeitschrift fur Gastroenterologie · 1999
    Narrative reviewZinc
  74. Efficacy of Zinc Supplement in Minimal hepatic Encephalopathy: A prospective, Randomized Controlled Study (Zinc-MHE Trial).
    Janyajirawong R; Vilaichone RK; Sethasine S · Asian Pacific journal of cancer prevention : APJCP · 2021
    Randomized trial69 participantsZinc
  75. Effect of zinc on liver cirrhosis with hyperammonemia: a preliminary randomized, placebo-controlled double-blind trial.
    Katayama K; Saito M; Kawaguchi T; Endo R; Sawara K; Nishiguchi S; Kato A; Kohgo H; Suzuki K; Sakaida I; Ueno Y; Habu D; Ito T; Moriwaki H; Suzuki K · Nutrition (Burbank, Los Angeles County, Calif.) · 2015
    Randomized trial18 participantsZinc
  76. Effects of low dose zinc supplementation on biochemical markers in non-alcoholic cirrhosis: a randomized clinical trial.
    Somi MH; Rezaeifar P; Ostad Rahimi A; Moshrefi B · Archives of Iranian medicine · 2012
    Randomized trial60 participantsZinc
  77. Correlation of Serum Zinc Levels with Hepatic Encephalopathy Severity in Patients with Decompensated Liver Cirrhosis: A Prospective Observational Study from Egypt.
    Semeya AA; Elgamal R; Othman AAA · Biological trace element research · 2025
    Observational study200 participantsZinc
  78. Metabolomic profiling reveals novel biomarkers of alcohol intake and alcohol-induced liver injury in community-dwelling men.
    Harada S; Takebayashi T; Kurihara A; Akiyama M; Suzuki A; Hatakeyama Y; Sugiyama D; Kuwabara K; Takeuchi A; Okamura T; Nishiwaki Y; Tanaka T; Hirayama A; Sugimoto M; Soga T; Tomita M · Environmental health and preventive medicine · 2016
    Cross-sectional study896 participantsGlutamic Acid
  79. The Use of Activated Charcoal to Treat Intoxications.
    Zellner T; Prasa D; Färber E; Hoffmann-Walbeck P; Genser D; Eyer F · Deutsches Arzteblatt international · 2020
    Narrative reviewActivated Charcoal
  80. [Electrochemically regulated hemosorption detoxification].
    Gol'din MM; Luzhnikov EA; Gol'dfarb IuS; Matiushkin VA; Zimina LN · Anesteziologiia i reanimatologiia · 1999
    Clinical trialActivated Charcoal
  81. Effects of interrupting the enterohepatic circulation in amatoxin intoxications.
    Varekamp J; Tan JL; Stam J; van den Berg AP; van Rheenen PF; Touw DJ; Dekkers BGJ · Clinical toxicology (Philadelphia, Pa.) · 2024
    Systematic review1,119 participants133 studies pooledActivated Charcoal
  82. New developments in the therapy of intoxications.
    Krenzelok EP · Toxicology letters · 2002
    Narrative reviewActivated Charcoal
  83. Comparative Evaluation of Chlorella vulgaris and Anabaena variabilis for Phycoremediation of Polluted River Water: Spotlighting Heavy Metals Detoxification.
    Ahammed MS; Baten MA; Ali MA; Mahmud S; Islam MS; Thapa BS; Islam MA; Miah MA; Tusher TR · Biology · 2023
    OtherBlue-Green Algae
  84. Beyond carbon capture: bioengineering cyanobacteria as solar-driven platforms for remediation of recalcitrant human-generated waste.
    Seiilbek SN; Mirza SS; Torekhanova MM; Altybaeva NA; Sydykbekova RK; Akmukhanova NR; Bruce BD · Frontiers in plant science · 2026
    Narrative reviewBlue-Green Algae
  85. Efficacy of spirulina extract plus zinc in patients of chronic arsenic poisoning: a randomized placebo-controlled study
    Mir Misbahuddin et al. · Clinical Toxicology · 2006
    Randomized trial41 participantsBlue-Green Algae
  86. Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).
    Gross-Steinmeyer K; Eaton DL · Toxicology · 2012
    Narrative reviewChlorophyllin
  87. Aflatoxin and Liver Cancer in China: The Evolving Research Landscape.
    Chen JG; Kensler TW; Sun GJ; Zhu J; Lu JH; Pan D; Zhang YH; Groopman JD · Toxins · 2026
    Narrative reviewChlorophyllin
  88. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer
    P A Egner, J B Wang, Y R Zhu, B C Zhang, Y Wu, Q N Zhang, G S Qian, S Y Kuang, S J Gange, L P Jacobson, K J Helzlsouer, G S Bailey, J D Groopman, T W Kensler · Proceedings of the National Academy of Sciences of the United States of America · 2001
    Randomized trial169 participantsChlorophyllin
  89. Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients.
    Hussain M; Habib-Ur-Rehman; Akhtar L · Pakistan journal of medical sciences · 2024
    Randomized trial80 participantsGreen Tea
  90. The Effect of Green Tea Extract Supplementation on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease.
    Pezeshki A; Safi S; Feizi A; Askari G; Karami F · International journal of preventive medicine · 2016
    Randomized trial80 participantsGreen Tea
  91. Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study.
    Sakata R; Nakamura T; Torimura T; Ueno T; Sata M · International journal of molecular medicine · 2014
    Randomized trial17 participantsGreen Tea
  92. Green tea consumption is associated with decreased DNA damage among GSTM1-positive smokers regardless of their hOGG1 genotype.
    Hakim IA; Chow HH; Harris RB · The Journal of nutrition · 2008
    Randomized trialGreen Tea
  93. Modulation of human glutathione s-transferases by polyphenon e intervention.
    Chow HH; Hakim IA; Vining DR; Crowell JA; Tome ME; Ranger-Moore J; Cordova CA; Mikhael DM; Briehl MM; Alberts DS · Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2007
    Single-arm trial42 participantsGreen Tea